These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9134316)

  • 1. In vivo characterization of host and bacterial protease expression during Pseudomonas aeruginosa corneal infections in naive and immunized mice.
    Kernacki KA; Fridman R; Hazlett LD; Lande MA; Berk RS
    Curr Eye Res; 1997 Apr; 16(4):289-97. PubMed ID: 9134316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo bacterial protease production during Pseudomonas aeruginosa corneal infection.
    Kernacki KA; Hobden JA; Hazlett LD; Fridman R; Berk RS
    Invest Ophthalmol Vis Sci; 1995 Jun; 36(7):1371-8. PubMed ID: 7775115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relevance of host-derived and bacterial factors in Pseudomonas aeruginosa corneal infections.
    Steuhl KP; Döring G; Henni A; Thiel HJ; Botzenhart K
    Invest Ophthalmol Vis Sci; 1987 Sep; 28(9):1559-68. PubMed ID: 3305411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corneal virulence of Pseudomonas aeruginosa elastase B and alkaline protease produced by Pseudomonas putida.
    Thibodeaux BA; Caballero AR; Marquart ME; Tommassen J; O'Callaghan RJ
    Curr Eye Res; 2007 Apr; 32(4):373-86. PubMed ID: 17453960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of virulence factors in Pseudomonas aeruginosa strains isolated from contact lens-associated corneal ulcers.
    Pinna A; Usai D; Sechi LA; Molicotti P; Zanetti S; Carta A
    Cornea; 2008 Apr; 27(3):320-6. PubMed ID: 18362661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudomonas aeruginosa MucD protease mediates keratitis by inhibiting neutrophil recruitment and promoting bacterial survival.
    Mochizuki Y; Suzuki T; Oka N; Zhang Y; Hayashi Y; Hayashi N; Gotoh N; Ohashi Y
    Invest Ophthalmol Vis Sci; 2014 Jan; 55(1):240-6. PubMed ID: 24255043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The significance of bacterial and host factors in corneal infections caused by Pseudomonas aeruginosa].
    Steuhl KP; Döring G; Thiel HJ
    Fortschr Ophthalmol; 1989; 86(4):283-6. PubMed ID: 2507425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alkaline protease-deficient mutants of Pseudomonas aeruginosa are virulent in the eye.
    Pillar CM; Hazlett LD; Hobden JA
    Curr Eye Res; 2000 Sep; 21(3):730-9. PubMed ID: 11120561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Pseudomonas aeruginosa strain isolated from a contact lens-induced acute red eye (CLARE) is protease-deficient.
    Estrellas PS; Alionte LG; Hobden JA
    Curr Eye Res; 2000 Mar; 20(3):157-65. PubMed ID: 10694889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection.
    Preston MJ; Gerçeker AA; Koles NL; Pollack M; Pier GB
    Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1418-25. PubMed ID: 9191605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secretory IgA inhibits Pseudomonas aeruginosa binding to cornea and protects against keratitis.
    Masinick SA; Montgomery CP; Montgomery PC; Hazlett LD
    Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):910-8. PubMed ID: 9112987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A live-attenuated Pseudomonas aeruginosa vaccine elicits outer membrane protein-specific active and passive protection against corneal infection.
    Zaidi TS; Priebe GP; Pier GB
    Infect Immun; 2006 Feb; 74(2):975-83. PubMed ID: 16428743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of Pseudomonas aeruginosa Small Protease (PASP), a Corneal Virulence Factor.
    Tang A; Caballero AR; Marquart ME; Bierdeman MA; O'Callaghan RJ
    Invest Ophthalmol Vis Sci; 2018 Dec; 59(15):5993-6002. PubMed ID: 30572344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Pseudomonas aeruginosa elastase, alkaline protease, and exotoxin A on corneal proteinases and proteins.
    Twining SS; Kirschner SE; Mahnke LA; Frank DW
    Invest Ophthalmol Vis Sci; 1993 Aug; 34(9):2699-712. PubMed ID: 8344792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic effect of immunization with OEP, protease toxoid and elastase toxoid on corneal ulcers in mice due to Pseudomonas aeruginosa infection.
    Hirao Y; Homma JY
    Jpn J Exp Med; 1978 Feb; 48(1):41-51. PubMed ID: 97424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of protease activity in human otitis media.
    Avidano MA; Cotter CS; Stringer SP; Schultz GS
    Otolaryngol Head Neck Surg; 1998 Oct; 119(4):346-51. PubMed ID: 9781988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudomonas aeruginosa proteases and corneal virulence.
    Hobden JA
    DNA Cell Biol; 2002; 21(5-6):391-6. PubMed ID: 12167241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic and therapeutic vaccine against Pseudomonas aeruginosa keratitis using bacterial membrane vesicles.
    Ito S; Nakamura J; Fukuta M; Ura T; Teshigawara T; Fukushima J; Mizuki N; Okuda K; Shimada M
    Vaccine; 2021 May; 39(23):3152-3160. PubMed ID: 33934918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testican-1 promotes resistance against Pseudomonas aeruginosa-induced keratitis through regulation of MMP-2 expression and activation.
    Berger EA; McClellan SA; Barrett RP; Hazlett LD
    Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5339-46. PubMed ID: 21613368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization against experimental Pseudomonas aeruginosa and Serratia marcescens keratitis. Vaccination with lipopolysaccharide endotoxins and proteases.
    Kreger AS; Lyerly DM; Hazlett LD; Berk RS
    Invest Ophthalmol Vis Sci; 1986 Jun; 27(6):932-9. PubMed ID: 3519522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.